Comments
Loading...

Biogen

BIIBNASDAQ
Logo brought to you by Benzinga Data
$197.59
00.00%
Pre-Market: 4:27 PM EDT
15 minutes delayed
Consensus Rating1
Buy
Highest Price Target1
$373.00
Lowest Price Target1
$190.00
Consensus Price Target1
$278.00

Biogen (NASDAQ:BIIB) Stock, Analyst Ratings, Price Targets, Forecasts

Biogen Inc has a consensus price target of $278 based on the ratings of 24 analysts. The high is $373 issued by Morgan Stanley on November 10, 2023. The low is $190 issued by Barclays on August 2, 2024. The 3 most-recent analyst ratings were released by Cantor Fitzgerald, Needham, and Needham on September 9, 2024, September 4, 2024, and August 19, 2024, respectively. With an average price target of $287.33 between Cantor Fitzgerald, Needham, and Needham, there's an implied 45.42% upside for Biogen Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
1
May
3
Jun
2
Jul
2
3
Aug
1
Sep
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
3.5
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Cantor Fitzgerald
Needham
Mizuho
Truist Securities
RBC Capital

1calculated from analyst ratings

Analyst Ratings for Biogen

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for Biogen (BIIB) stock?

A

The latest price target for Biogen (NASDAQ:BIIB) was reported by Cantor Fitzgerald on September 9, 2024. The analyst firm set a price target for $292.00 expecting BIIB to rise to within 12 months (a possible 47.78% upside). 66 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Biogen (BIIB)?

A

The latest analyst rating for Biogen (NASDAQ:BIIB) was provided by Cantor Fitzgerald, and Biogen reiterated their overweight rating.

Q

When was the last upgrade for Biogen (BIIB)?

A

The last upgrade for Biogen Inc happened on December 7, 2023 when Raymond James raised their price target to $283. Raymond James previously had a market perform for Biogen Inc.

Q

When was the last downgrade for Biogen (BIIB)?

A

The last downgrade for Biogen Inc happened on February 14, 2024 when Wells Fargo changed their price target from $315 to $240 for Biogen Inc.

Q

When is the next analyst rating going to be posted or updated for Biogen (BIIB)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Biogen, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Biogen was filed on September 9, 2024 so you should expect the next rating to be made available sometime around September 9, 2025.

Q

Is the Analyst Rating Biogen (BIIB) correct?

A

While ratings are subjective and will change, the latest Biogen (BIIB) rating was a reiterated with a price target of $292.00 to $292.00. The current price Biogen (BIIB) is trading at is $197.59, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch